BRAF and melanoma: Atkins Atkins MB MB Lee Lee SJ SJ Chmielowski Chmielowski B B Tarhini Tarhini AA AA Cohen Cohen GI GI Truong Truong TG TG Combination dabrafenib and trametinib versus combination nivolumab and ipilimumab for patients with advanced BRAF-mutant melanoma: the DREAMseq trial-ECOG-ACRIN EA6134 Combination dabrafenib and trametinib versus combination nivolumab and ipilimumab for patients with advanced BRAF-mutant melanoma: the DREAMseq trial-ECOG-ACRIN EA6134 J Clin Oncol J Clin Oncol 2023 2023 41 41 186 186 97 97 10.1200/JCO.22.01763 10.1200/JCO.22.01763 36166727 36166727